Julius Juhyun Chung1 and Tao Jin1
1University of Pittsburgh, Pittsburgh, PA, United States
Synopsis
Average Saturation Efficiency Filter (ASEF) is a
fast and intuitive technique for achieving CEST imaging with improved
sensitivity removing fast exchanges and semi-solid MT background with minimal
loss to sensitivity. Our results in MCAO rodents showed that it can detect the
ischemic lesion from CEST signal contrasts at 3.6, 2.6, and 2 ppm which may
provide different metabolic-related information with higher sensitivity to
3-point measurement at 3.6 ppm and comparable contrast. Its low requirement on
number of imaged signals also opens up possibilities for dynamic imaging or
signal averaging.
Introduction
CEST
MRI signal is usually contaminated by magnetization transfer (MT) from
semi-solids and overlapping faster, broad exchanges. Numerous solutions have
been proposed to remove confounding effects but these methods often either increase
acquisition time or sacrifice sensitivity1-4. We proposed an Average Saturation Efficiency
Filter (ASEF) for CEST imaging (detailed theory presented in another
abstract). This method uses two pulse trains with similar average saturation
power but highly unequal duty cycles, so that saturation transfer effects from fast
chemical exchange species and semisolid macromolecules are similar between the
two pulse trains, but drastically different for slow exchange species. Thus, their difference
becomes an exchange rate filter suppressing MT and fast exchange signals. In this study, we demonstrate the
implementation of ASEF imaging in vivo in the rat brain and examine its
sensitivity in detecting ischemia in rats with Middle Cerebral Artery Occlusion
(MCAO).Methods
Imaging of MCAO rats
(n=6) was performed 3-4 hours post-operation using 4-s saturation preparation
with average B1=0.80 μT applied at 36 offsets (0-6 ppm) comprising
either a Continuous Wave (CW) pulse or a train of 25 binomial pairs of Gaussian
pulses with kurtosis of 4 with duration=24 ms and pulse interval=136 ms,
yielding a duty cycle (DC) of ~15%. Two slice spin-echo EPI was read-out:
matrix size= 80×80, field of view= 32×32 mm, slice thickness= 2 mm, TR= 7 s and
TE= 20 ms. It has been reported that the MT signal can be slightly different
for two saturations with the same average B1 power but highly
unequal DCs5. Thus, MT matching was performed to determine a small
fudge factor for the low DC pulse train, so as to minimize this residue MT
effect. CEST maps were obtained with CW at 5.5 ppm with fixed B1=0.80
μT as well as with a binomial pair pulse train where average B1 was modulated
by a fudge factor between 0 and ± 3.6% in 0.4% increments. Signal from ROIs of normal tissue saturated
by CW was compared to the pulse train, linearly interpolating to find the fudge
factor that matches the two signals. Any remnant baseline difference at 5-6 ppm
was subtracted directly from ASEF signals across offsets. CEST signals were
calculated as follows: ASEFΩ= SΩ,low DC/S0,low DC–SΩ,CW/S0,CW
where Ω is frequency offset, low DC refers to saturation by low duty cycle
binomial pulse train, and S0 images were acquired at 300 ppm; and
APT*= ((S4.2ppm+S3.0ppm)/2-S3.6ppm)/S06.Results
The positive offsets of the Z-spectra averaged over animals are shown for
ROIs selected from the contralesional hemisphere (Fig.1a) and from infarcts
(Fig.1b). The CW and low DC spectra closely matched at >5 ppm and show peaks
around the amide (~3.6 ppm), guanidyl (~2 ppm), and phosphocreatine signal (2.6
ppm). ASEF signals (Fig.1c) at 3.6 ppm, 2 ppm, and 2.6 ppm in the
contralateral/lesion were about 2.9%/1.6%, 2.3%/2.2%, and 2.0%/1.1%,
respectively. APT*
and 3.6 ppm ASEF (APTASEF)
calculated from the spectra averaged over the lesion/contralateral (Fig.1d)
were 1.21±0.4%/2.43±0.1% and 1.6±0.4%/2.9±0.4%, respectively. Maps of an exemplary rodent were compared for
ADC, APTASEF, APT*, ASEF
at 2.0 ppm, and ASEF at 2.6 ppm (Fig.1e). There was comparable contrast for APTASEF
and APT* between ischemic and normal tissue with ASEF maps at 2.0 ppm showing
limited contrast between the lesion and normal tissue while 2.6 ppm maps clearly
depicting the lesion. There is
heterogeneity in the lesion for 2.0 ppm with hypointensity corresponding to
deeper hypointensity at 2.6 and 3.6 ppm and hyperintensity corresponding to
reduced hypointensity. Discussion
The 3-point method has been used to measured APT
with good sensitivity and specificity, but it requires high field so that the 3.6
ppm amide peak is distinct. It is also difficult to apply at 2.6 ppm where the
peak of PCr is small, and at the 2 ppm guanidyl group where direct water
saturation is large. Using a high DC pulse train or CW to effectively saturate
the labile protons and a low DC pulse train as the baseline, ASEF can be
acquired at the Larmor frequency of a labile proton. ASEF showed similar contrast to 3-point
measurement with increased signal sensitivity. ASEF showed larger inter-animal variation,
likely due to MT matching introducing an additional factor of variability. As actual variation in matching was within a
few percent of the B1 peak power, standardizing the match across
animals could reduce variation with limited detriment on the accuracy of ASEF
signal. The close signal for ASEF at 2 ppm in the lesion and contralateral was
likely due to the exchange rate tuning effect at 0.80 μT7. Conclusion
ASEF is a fast and intuitive technique for
achieving CEST imaging with improved sensitivity removing fast exchanges and
semi-solid MT background with minimal loss to sensitivity. Our results showed
that it can detect the ischemic lesion from CEST signal contrasts at 3.6, 2.6,
and 2 ppm which may provide different metabolic-related information. Its low
requirement on number of imaged signals also opens up possibilities for dynamic
imaging or signal averaging. Acknowledgements
This work is supported by NIH grant NS100703.References
- Zaiss M, et al. J Magn Reson 2011;211(2):149-55.
- Zu Z, et al. Magn Reson Med 2013;69(3):637-647.
- Xu X, et al. Magn Reson Med 2016;75(1):88-96.
- Chen L, et al. Magn Reson Med 2019;81(1):69-78.
- Varma G, et al. J Magn Reson 2018;296:60-71.
- Jin T, et al. Magn Reson Med. 2013; 69(3): 760–770.
- Jin T. et al. Neuroimage. 2017; 157: 341–350.